USP 797 Sterile Compounding Compliance
What this clause says
Vendor shall maintain documentation of compliance with USP General Chapter <797> covering sterile compounding, including current SOPs, environmental monitoring records, and personnel competency files, available for inspection upon Sponsor request.
What this means in plain English
USP 797 governs preparation of compounded sterile preparations. Insurance riders increasingly require documented compliance, validated cleanrooms, and current SOPs to underwrite druggist professional liability and products coverage.
What it means for a CDMO program
Carriers will now decline or non-renew compounding pharmacies with lapsed USP 797 documentation or unaddressed Form 483 observations. The 2023 USP 797 revision tightened beyond-use dating and environmental monitoring requirements — pharmacies that updated SOPs to comply have a smoother renewal experience than those that did not.
Carrier notes
Specialty carriers serving 503A and 503B operations all require current USP 797 inspection-readiness as an underwriting condition.
How this evaluates
The Decoder applies these rules in order; the first match wins.
- usp797 › compliant is set → Compliant: Compliant USP 797 SOPs and validation documented.
- usp797 › compliant is not set → Gap: No USP 797 compliance documented — carriers will likely require remediation before binding.
See this in your MSA
Pre-loaded with this clause selected.
Run the Decoder